ChemicalBook > CAS DataBase List > abciximab

abciximab

Product Name
abciximab
CAS No.
143653-53-6
Chemical Name
abciximab
Synonyms
Reopro;Rheopro;CentoRx;c7E3 Fab;Abcixifiban;Unii-X85G7936gv;Research Grade Abciximab(DHC33301);Immunoglobulin G1, (human-mouse monoclonal c7E3 clone p7E3VHhCgamma1 Fab fragment anti-human glycoprotein IIb/IIIa receptor), disulfide with human-mouse monoclonal c7E3 clone p7E3VkappahCkappa light chain
CBNumber
CB51319184
Formula Weight
0
MOL File
Mol file
More
Less

abciximab Property

storage temp. 
Store at -80°C
More
Less

Safety

Hazardous Substances Data
143653-53-6(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
ATB0010203
Product name
ABCIXIMAB
Purity
98.00%
Packaging
5MG
Price
$498
Updated
2021/12/16
More
Less

abciximab Chemical Properties,Usage,Production

Uses

Monoclonal antibody (antithrombotic).

brand name

ReoPro (Lilly).

Clinical Use

Antiplatelet agent:
Prevention of ischaemic cardiac complications in patients undergoing percutaneous coronary intervention
Short-term prevention of myocardial infarction in patients with unstable angina not responding to treatment or awaiting percutaneous coronary intervention.

Enzyme inhibitor

This antithrombotic (MW = 47455 g/mol; CAS 143653-53-6; also known as Reopro?) consists of an immunoglobulin G1 Fab fragment from a chimeric human-murine monoclonal antibody directed against the human platelet glycoprotein IIb/IIIa receptor. Abciximab also facilitates the dispersal of newly formed platelet aggregates in vitro, by partially displacing fibrinogen from activated GPIIb/IIIareceptors. In vivo, abciximab may destabilize coronary thrombi by preventing aggregate formation and dispersing mural thrombi. Target(s): coagulation factor Xa, in presence of heparin; glycoprotein IIb/IIIa receptor.

Drug interactions

Potentially hazardous interactions with other drugs
Heparin, anticoagulants, antiplatelets and thrombolytics: increased risk of bleeding.

Metabolism

Following IV administration, abciximab rapidly binds to the platelet GPIIb/IIIa receptors, and remains in the circulation for 15 days or more in a platelet-bound state. Metabolism is via proteolytic cleavage

abciximab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

abciximab Suppliers

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2127
Advantage
70
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12338
Advantage
58
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9709
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10055
Advantage
58
Wuhan Topule
Tel
+86-02787215551 +86-19945035818
Fax
027-87215551
Email
2936752263@qq.com
Country
China
ProdList
7955
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7977
Advantage
58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd
Tel
17691182729 18161915376
Email
1046@dideu.com
Country
China
ProdList
10010
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
+86-027-59232304 15387063101
Email
2881924050@qq.com
Country
China
ProdList
9892
Advantage
58
AntibodySystem
Tel
027-65279366 18162686757
Email
biolab-reagents@atagenix.com
Country
China
ProdList
9800
Advantage
58

143653-53-6, abciximabRelated Search:


  • Reopro
  • Unii-X85G7936gv
  • CentoRx
  • Immunoglobulin G1, (human-mouse monoclonal c7E3 clone p7E3VHhCgamma1 Fab fragment anti-human glycoprotein IIb/IIIa receptor), disulfide with human-mouse monoclonal c7E3 clone p7E3VkappahCkappa light chain
  • Rheopro
  • Research Grade Abciximab(DHC33301)
  • Abcixifiban
  • c7E3 Fab
  • 143653-53-6